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Background:  Outcomes of post-HT patients in transition (13y to 24y) have not been well described.
methods:  45213 HT recipients were identified from UNOS (1987-2011) and stratified by age group (pediatric (age 24, n=38322).
exclusions: re-HT & lost to follow up. Survival was censored at 12y. Multivariate Cox proportional hazard regression analysis was adjusted 
for sex, DM, race, ischemic time, dialysis, life support, VAD use, wait time & HLA mismatch. Transition and pediatric patients were more 
likely to be listed status 1 for HT (p < 0.001), receive a younger donor (p<0.001) and have less prior cardiac surgery (p<001) compared to 
adults. The adult and transition were more likely to have elevated creatinine (p<0.001), to be bridged with VAD (p<0.001) and wait longer 
for transplant than the pediatric group (p<0.001). There was less cardiovascular death in the adult group (p<0.001) with significantly less 
graft failure and rejection (Pediatric vs Transition vs Adult: 12 vs 9 vs 6% and 20 vs 23 vs 8%, respectively (p<0.001)). Survival (1, 5 & 10y) 
was: Pediatric (82, 70, 59%), transition (87, 65, 46%) & adult (86, 71, 50%) (Figure). Unadjusted HR (vs transitional group) for all-cause 
mortality was: Adult: 0.92 (CI 0.87-0.98) and Pediatric: 0.79 (0.73-0.85). Multivariate analysis yielded a HR of: Adult: 0.88 (CI 0.82-0.95) 
and Pediatric: 0.71 (0.65-0.78).
conclusion:  Despite better survival early post HT, the transition group survival declines over time and is significantly worse compared to 
the adult and pediatric group.
 
